Astragaloside IV attenuates penicillin-induced epilepsy via inhibiting activation of the MAPK signaling pathway

Zhu,Xingming; Chen,Yang; Du,Yuping; Wan,Qi; Xu,Yan; Wu,Jiayu

doi:10.3892/mmr.2017.7896

Astragaloside IV attenuates penicillin-induced epilepsy via inhibiting activation of the MAPK signaling pathway

Authors:
- Xingming Zhu
- Yang Chen
- Yuping Du
- Qi Wan
- Yan Xu
- Jiayu Wu
View Affiliations

Affiliations: Department of Neurology, 101st Hospital of Chinese People's Liberation Army, Wuxi, Jiangsu 214044, P.R. China
Published online on: October 26, 2017 https://doi.org/10.3892/mmr.2017.7896
Pages: 643-647

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Astrocytes perform several functions in the brain and spinal cord. Penicillin is commonly used for establishment of experimental epilepsy models. Previous studies have demonstrated that astragaloside IV (3-o-β-d-xylopyranosyl-6-o-β-d-glucopyranosyl-cycloastragenol; AS‑IV) has comprehensive pharmacological functions on the attenuation of inflammation. In the present study, primary astrocyte cell cultures were divided into three groups: Control group, penicillin (2,500 µM) treatment group (epilepsy model), and penicillin+AS‑IV (20, 40, 80 and 160 µmol/l) treatment group. The expression levels of inflammatory factors, including interleukin‑1β and tumor necrosis factor‑α, were determined in the groups using western blot and reverse transcription‑quantitative polymerase chain reaction analyses. The levels of members of the phosphorylated‑mitogen‑activated protein kinase (p‑MAPK) family, including p‑c‑Jun N‑terminal kinase 1/2, p‑extracellular signal‑regulated protein kinase 1/2 and p‑p38, were determined using western blot analysis. Cell viability of the astrocytes was detected using a 3‑(4,5‑dimethyl‑2‑thiazolyl)‑2,5‑diphenyl‑2‑H‑tetrazolium bromide assay and cell proliferation was evaluated using a Cell Counting Kit‑8 assay. The results revealed that AS‑IV significantly suppressed the expression of penicillin‑induced inflammatory factors in the astrocytes at the transcriptional and translational levels, and occurred in a dose‑dependent manner. The penicillin‑induced increase in the protein levels of the the p‑MAPK family were notably decreased by AS‑IV. In addition, the penicillin‑induced downregulation of primary astrocyte viability/cell proliferation was significantly reversed by the administration of AS‑IV. From these results, it was concluded that AS‑IV suppressed the penicillin‑induced upregulation of inflammatory factors and p‑MAPK in astrocytes, ultimately attenuating epilepsy.

View Figures

View References

1	Chang BS and Lowenstein DH: Epilepsy. N Engl J Med. 349:1257–1266. 2003. View Article : Google Scholar : PubMed/NCBI
2	Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Glynn M, et al: ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 55:475–482. 2014. View Article : Google Scholar : PubMed/NCBI
3	Thurman DJ, Beghi E, Begley CE, Berg AT, Buchhalter JR, Ding D, Hesdorffer DC, Hauser WA, Kazis L, Kobau R, et al: Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia. 52 Suppl 7:S2–S26. 2011. View Article : Google Scholar
4	EpilepsyFact Sheets. World Health Organization; 2012
5	GBD 2013 Mortality and Causes of Death Collaborators: regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 385:117–171. 2013.
6	Farina C, Aloisi F and Meinl E: Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28:138–145. 2007. View Article : Google Scholar : PubMed/NCBI
7	Seifert G, Carmignoto G and Steinhäuser C: Astrocyte dysfunction in epilepsy. Brain Res Rev. 63:212–221. 2010. View Article : Google Scholar : PubMed/NCBI
8	Aronica E and Crino PB: Inflammation in epilepsy: Clinical observations. Epilepsia. 52 Suppl 3:S26–S32. 2011. View Article : Google Scholar
9	Vezzani A, Ravizza T, Balosso S and Aronica E: Glia as a source of cytokines: Implications for neuronal excitability and survival. Epilepsia. 49 Suppl 2:S24–S32. 2008. View Article : Google Scholar
10	Bizière K and Chambon JP: Animal models of epilepsy and experimental seizures. Rev Neurol (Paris). 143:329–340. 1987.(In French). PubMed/NCBI
11	Fisher RS: Animal models of the epilepsies. Brain Res Brain Res Rev. 14:245–278. 1989. View Article : Google Scholar : PubMed/NCBI
12	Twyman RE, Green RM and MacDonald RL: Kinetics of open channel block by penicillin of single GABAA receptor channels from mouse spinal cord neurons in culture. J Physiol. 445:97–127. 1992. View Article : Google Scholar : PubMed/NCBI
13	Qiu YY, Zhu JX, Bian T, Gao F, Qian XF, Du Q, Yuan MY, Sun h, Shi LZ and Yu H: Protective effects of Astragaloside IV against ovalbumin-induced lung inflammation are regulated/mediated by T-bet/GATA-3. Pharmacol. 94:51–59. 2014. View Article : Google Scholar
14	Qiu L, Yin G, Cheng L, Fan Y, Xiao W, Yu G, Xing M, Jia R, Sun R, Ma X, et al: Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB. Int J Mol Med. 35:625–636. 2015. View Article : Google Scholar : PubMed/NCBI
15	Özdemir MB, Akça H, Erdoğan Ç, Tokgün O, Demiray A, Semin F and Becerir C: Protective effect of insulin and glucose at different concentrations on penicillin-induced astrocyte death on the primer astroglial cell line. Neural Regen Res. 7:1895–1899. 2012.PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR and Zalutsk R: How common are the ‘common’ neurologic disorders? Neurol. 68:326–337. 2007. View Article : Google Scholar
18	Brodie MJ, Elder AT and Kwan P: Epilepsy in later life. Lancet Neurol. 8:1019–1030. 2009. View Article : Google Scholar : PubMed/NCBI
19	Holmes, Thomas R. Browne and Gregory L: Handbook of epilepsy. 4th edition. Philadelphia: Lippincott Williams & Wilkins; pp. 7ISBN 978-0-7817-7397-3. 2008
20	Noebels JL, Avoli M, Rogawski MA, et al: Jasper's Basic Mechanisms of the Epilepsies. Oxford University Press; pp. 466–470. 2012
21	Bromfield EB, Cavazos JE and Sirven JI: An introduction to epilepsy. American Epilepsy Society. 2006.
22	Blumenfeld H: Cellular and network mechanisms of spike-wave seizures. Epilepsia. 46:21–33. 2005. View Article : Google Scholar : PubMed/NCBI
23	Sofroniew MV and Vinters HV: Astrocytes: Biology and pathology. Acta Neuropathol. 119:7–35. 2010. View Article : Google Scholar : PubMed/NCBI
24	Vezzani A, Maroso M, Balosso S, Sanchez MA and Bartfai T: IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun. 25:1281–1289. 2011. View Article : Google Scholar : PubMed/NCBI
25	Vezzani A, French J, Bartfai T and Baram TZ: The role of inflammation in epilepsy. Nat Rev Neurol. 7:31–40. 2011. View Article : Google Scholar : PubMed/NCBI
26	Vezzani A, Balosso S and Ravizza T: The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun. 22:797–803. 2008. View Article : Google Scholar : PubMed/NCBI
27	Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG and Vezzani A: Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol. 57:804–812. 2005. View Article : Google Scholar : PubMed/NCBI
28	Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noé F, Malva J, Randle JC, Allan S and Vezzani A: Inactivation of caspase-1 in rodent brain: A novel anticonvulsive strategy. Epilepsia. 47:1160–1168. 2006. View Article : Google Scholar : PubMed/NCBI
29	Bellinger FP, Madamba S and Siggins GR: Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:227–234. 1993. View Article : Google Scholar : PubMed/NCBI
30	Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A and Besedovsky H: A neuromodulatory role of interleukin-1beta in the hippocampus. Ann NY Acad Sci. 95:7778–7783. 1998. View Article : Google Scholar
31	Allan SM, Tyrrell PJ and Rothwell NJ: Interleukin-1 and neuronal injury. Nat Rev Immunol. 5:629–640. 2005. View Article : Google Scholar : PubMed/NCBI